» Articles » PMID: 28646714

Synthetic Cathinones and Stereochemistry: S Enantiomer of Mephedrone Reduces Anxiety- and Depressant-like Effects in Cocaine- or MDPV-abstinent Rats

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2017 Jun 25
PMID 28646714
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: The neuropharmacological profile of the synthetic cathinone mephedrone (MEPH) is influenced by stereochemistry. Both MEPH enantiomers are monoamine transporter substrates, but R-MEPH is primarily responsible for rewarding effects of MEPH as it produces greater locomotor activation and intracranial self-stimulation than S-MEPH. S-MEPH is a 50-fold more potent 5-HT releaser than R-MEPH and does not place preference in rats. MEPH is also structurally similar to the cathinone derivative bupropion, an antidepressant and smoking cessation medication, suggesting MEPH has therapeutic and addictive properties.

Methods: We tested the hypothesis that S-MEPH reduces anxiety- and depression-like behaviors in rats withdrawn from chronic cocaine or methylenedioxypyrovalerone (MDPV) using the elevated plus maze (EPM) and forced swim test (FST), respectively. Rats were tested 48-h after a binge-like paradigm (3×/day for 10days in 1-h intervals) of cocaine (10mg/kg), MDPV (1mg/kg) or saline. In vitro studies assessed the receptor binding and activity of S-MEPH.

Key Results: Rats withdrawn from chronic cocaine or MDPV displayed an increase in anxiety- and depression-like behaviors that was antagonized by treatment with S-MEPH (10, 30mg/kg). S-MEPH displayed affinity, but not agonist activity, for 5-HT receptors (2A-2C) and showed negligible affinity for dopaminergic, adrenergic and nicotinic receptors.

Conclusion And Implication: S-MEPH attenuated withdrawal behaviors following chronic cocaine or MDPV, perhaps through 5-HT release and/or 5-HT receptor interactions. The present data suggest S-MEPH may be a possible structural and pharmacological template to develop maintenance therapy for acute anxiety and depression during early withdrawal from psychostimulant abuse.

Citing Articles

From Psychoactivity to Antimicrobial Agents: Multifaceted Applications of Synthetic Cathinones and Extracts.

Andres C, Perez de la Lastra J, Munguira E, Juan C, Perez-Lebena E Molecules. 2025; 29(24.

PMID: 39770007 PMC: 11679858. DOI: 10.3390/molecules29245918.


Structure-Activity Relationship of Synthetic Cathinones: An Updated Review.

Nadal-Gratacos N, Pazos M, Pubill D, Camarasa J, Escubedo E, Berzosa X ACS Pharmacol Transl Sci. 2024; 7(9):2588-2603.

PMID: 39296271 PMC: 11406692. DOI: 10.1021/acsptsci.4c00299.


Opposite Contractile Effects of Amphetamine-Related Hallucinogenic Drugs in the Isolated Human Atrium.

Neumann J, Hofmann B, Gergs U Int J Mol Sci. 2024; 25(16).

PMID: 39201573 PMC: 11354304. DOI: 10.3390/ijms25168887.


Effects of congeners of amphetamine on the human heart.

Neumann J, Dhein S, Kirchhefer U, Hofmann B, Gergs U Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(7):4615-4642.

PMID: 38340182 PMC: 11166837. DOI: 10.1007/s00210-024-02983-2.


Blocking IL-17A prevents oxycodone-induced depression-like effects and elevation of IL-6 levels in the ventral tegmental area and reduces oxycodone-derived physical dependence in rats.

Inan S, Meissler J, Bessho S, Wiah S, Tukel C, Eisenstein T Brain Behav Immun. 2024; 117:100-111.

PMID: 38199516 PMC: 10932873. DOI: 10.1016/j.bbi.2024.01.001.


References
1.
Simmler L, Buser T, Donzelli M, Schramm Y, Dieu L, Huwyler J . Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2012; 168(2):458-70. PMC: 3572571. DOI: 10.1111/j.1476-5381.2012.02145.x. View

2.
Anneken J, Angoa-Perez M, Kuhn D . 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. J Neurochem. 2015; 133(2):211-22. PMC: 4759647. DOI: 10.1111/jnc.13048. View

3.
Lopez-Arnau R, Martinez-Clemente J, Pubill D, Escubedo E, Camarasa J . Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone. Br J Pharmacol. 2012; 167(2):407-20. PMC: 3481047. DOI: 10.1111/j.1476-5381.2012.01998.x. View

4.
Kehr J, Ichinose F, Yoshitake S, Goiny M, Sievertsson T, Nyberg F . Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats. Br J Pharmacol. 2011; 164(8):1949-58. PMC: 3246659. DOI: 10.1111/j.1476-5381.2011.01499.x. View

5.
Gawin F, KLEBER H . Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry. 1986; 43(2):107-13. DOI: 10.1001/archpsyc.1986.01800020013003. View